BioSpace News Archive

Business

Interim Report 1 January - 30 September 2019

Following a record first half year, sales weakened in the third quarter. However, the market situation and demand for our products remain favorable and we have confidence in our strategy

November 14, 2019
·
3 min read
Business

IRRAS AB publishes Interim Report for the Period January to September 2019

Since the US is the world’s largest market for neurosurgical procedures, we have focused much of our team’s resources toward supporting a successful early market introduction.

November 14, 2019
·
3 min read
Job Trends

“Nudging” Heart Patients to Take Their Statins Leads to Better Medication Adherence and Better Patient Outcomes, Intermountain Healthcare Study Finds

Statins are an effective medication for treating patients with heart disease – they cut the risk of a second major adverse cardiac event by almost 50 percent.

November 14, 2019
·
3 min read
Global Diabetic Neuropathy Drugs Market 2019-2023 - Evolving Opportunities with DAIICHI SANKYO COMPANY LIMITED and Eli Lilly and Company | Technavio

Technavio has announced its latest market research report titled global diabetic neuropathy drugs market 2019-2023

November 14, 2019
·
4 min read
Business

Cerecor Reports Third Quarter 2019 Results

Cerecor Inc. announced its financial results for the third quarter ended September 30, 2019 and provided additional corporate highlights.

November 14, 2019
·
12 min read
Business

VBL Therapeutics Announces Third Quarter 2019 Financial ResultsConference Call and Webcast at 8:30am Eastern Time Today

VBL Therapeutics announced financial results for the third quarter ended September 30, 2019, and provided a corporate update.

November 14, 2019
·
5 min read
Business

Stealth BioTherapeutics Reports Third Quarter 2019 Financial Results And Recent Business Highlights

Stealth BioTherapeutics Corp. reported financial results for the third quarter ended September 30, 2019 and provided a corporate update.

November 14, 2019
·
9 min read
Job Trends

Spectrum Pharmaceuticals to Present Corporate Update at the Jefferies 2019 London Healthcare Conference on November 21st

Spectrum Pharmaceuticals, a biopharmaceutical company focused on novel and targeted oncology therapies, announced that an overview of the company’s business strategy and development-stage programs will be given at the Jefferies 2019 London Healthcare Conference being held in London.

November 14, 2019
·
3 min read
Business

Acerus Reports Third Quarter and Year-to-Date Fiscal 2019 Financial Results

Acerus Pharmaceuticals Corporation reported its financial results for the three- and nine-month period ended September 30, 2019.

November 14, 2019
·
16 min read
Genetown

Cadent Therapeutics to Present at Upcoming Investor Conferences on November 2019

Cadent Therapeutics announced that Jodie Morrison, the Company’s Chief Executive Officer, will present at the following upcoming investor conferences

November 14, 2019
·
1 min read